The necessity of Aquamer using in patients with coronary artery disease

• Gubareva Irina V.

Abstract

In the article combination therapy necessity with the use of the drug Aquamer® of pharmaceutical company "Gedeon Richter” in coronary artery disease (CAD) is grounded. The effectiveness of the combination of amlodipine, lisinopri l, rosuvastatin for CAD treatment and prevention of cardiovascular complications was proved with taking into account the results of international studies.

Keywords:coronary artery disease, chronic coronary syndrome, combination therapy, Aquamer®, cardiovascular complications

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)